 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
: j$ o! ?: g. B4 ~, [: Y
/ G' k; I' g2 `. ~EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
+ e/ u& b# S& d6 [$ C ) d4 ?# d- x n0 ~
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
- Q$ Y' R! K- ~7 P+ D5 ~( m 3 }: Y5 B# F4 N9 q7 ?# }
/ E% P+ i% J# N
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.4 z2 l3 z! F* w! s( B' X% R
5 L* J5 m; V/ t! s4 ZThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."6 W1 W, z& r. {2 p5 E) L/ U7 H# R* Q
4 [1 p* D7 d; U9 O9 P: x, }/ d
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
. H" X' \: s7 z1 r% k6 K# a' u* u' l5 g; K, S
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.& v6 \0 Y& g2 b( A' S J
5 j3 l6 {, s: ?) ~/ D% l6 r/ ~
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
B( l! ^( j* U, X
0 G' i3 T8 F: O3 Q8 H- x( b1 R"As a scientist, it's one of the highlights of my CAREER," Shan said.
7 ~0 h% @0 [9 J; Y4 g5 W9 ^/ `/ E( _* w! Z! H# B$ c# t$ b
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."# Q6 V! ]) c X4 [! q: f
) I% m5 b+ ^: @$ k/ B
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.' s$ E* G# |7 N7 n
5 ^9 z/ G; h! b/ s" V1 VGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
- r( a( C2 i8 R4 p3 @' g1 u% _7 }# j0 _$ {! J
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
5 g2 Z- z0 [8 n5 q+ l6 d& J& @9 [: z# O6 ~, @5 w" P8 n
) o6 I" s" @9 I+ w# {% [. ?9 Ehttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
) ^" F6 y' ~/ o6 ]
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
